Vidaza and Plerixafor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vidaza (azacitidine) and Plerixafor (plerixafor). Common drug interactions include thrombocytosis among females and leukocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Vidaza and Plerixafor. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Vidaza?

Vidaza has active ingredients of azacitidine. It is often used in myelodysplastic syndrome. eHealthMe is studying from 12,837 Vidaza users. Check the latest studies of Vidaza.

What is Plerixafor?

Plerixafor has active ingredients of plerixafor. eHealthMe is studying from 694 Plerixafor users. Check the latest studies of Plerixafor.



On Jul, 18, 2026

14 people who take Vidaza and Plerixafor together, and have interactions are studied.

Vidaza and Plerixafor drug interactions.

What are the common drug interactions of Vidaza and Plerixafor, by gender? *:

female:

  1. Thrombocytosis
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Hyperbilirubinaemia (excess of bilirubin in the blood)
  4. Kidney infection
  5. Somnolence (a state of near-sleep, a strong desire for sleep)

male:

  1. Leukocytosis (increased white blood cells)
  2. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  3. Sinusitis fungal (fungal infection of sinus)
  4. Chest discomfort
  5. Death
  6. Dyspnoea (difficult or laboured respiration)
  7. Dyspnoea at rest (difficult or laboured breathing during rest)
  8. Marrow hyperplasia (increased bone marrow)
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Pneumonia

What are the common drug interactions of Vidaza and Plerixafor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Leukocytosis (increased white blood cells)
  2. Chest pain
  3. Chest discomfort
  4. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  5. Dyspnoea (difficult or laboured respiration)
  6. Dyspnoea at rest (difficult or laboured breathing during rest)
  7. Marrow hyperplasia (increased bone marrow)
  8. Thrombocytosis
  9. Tinnitus (a ringing in the ears)

60+:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Cellulitis (infection under the skin)
  3. Death
  4. Hyperbilirubinaemia (excess of bilirubin in the blood)
  5. Kidney infection
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Pneumonia
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Dysgeusia (disorder of the sense of taste)
  10. Epistaxis (bleed from the nose)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 2 people, 14.29%
  2. Stress And Anxiety: 1 person, 7.14%
  3. Presyncope: 1 person, 7.14%
  4. Nausea (feeling of having an urge to vomit): 1 person, 7.14%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
  6. High Blood Cholesterol: 1 person, 7.14%
  7. Haematopoietic Stem Cell Mobilisation: 1 person, 7.14%
  8. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 7.14%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.14%
  10. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vidaza and Plerixafor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vidaza and Plerixafor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vidaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Plerixafor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vidaza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plerixafor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on azacitidine and plerixafor (the active ingredients of Vidaza and Plerixafor, respectively), and Vidaza and Plerixafor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: